Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) Read more about Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) Read more about A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU) Read more about A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer Read more about A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer Read more about Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status Read more about Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status
Extended Access of Momelotinib in Adults With Myelofibrosis Read more about Extended Access of Momelotinib in Adults With Myelofibrosis
A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies Read more about A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) Read more about Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)